Financial Results 31-12-2024.
The Board Has Considered And Approved The Unaudited Consolidated & Standalone Financial Results Of The Company, For The Quarter Ended 31.12.2024 In Accordance With The Indian Accounting Standards (IND-AS) As Per Companies (Indian Accounting Standards
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Transgene Biotek Limited on 6ix
Earlier from Transgene Biotek
- Board Meeting Outcome for Outcome Of Board Meeting - Scrip Code 526139
- Transgene Biotek Limited. Press Release Jan 20 2025
- Statement Of Deviation & Variation
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Transgene Biotek Limited. Press Release Jan 16 2025
Later from Transgene Biotek
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Transgene Biotek Limited. Press Release Feb 12 2025
- Integrated Filing (Financial)
- Transgene Biotek Limited. Press Release Feb 14 2025
- Closure of Trading Window
Follow Transgene Biotek into a list and get an email when it puts out news.
Follow Transgene Biotek